U.S. Physical Therapy (NYSE:USPH) COO Sells $52,205.32 in Stock

U.S. Physical Therapy, Inc. (NYSE:USPH) COO Graham Reeve sold 662 shares of the stock in a transaction on Wednesday, March 11th. The stock was sold at an average price of $78.86, for a total value of $52,205.32. Following the sale, the chief operating officer directly owned 30,078 shares of the company’s stock, valued at approximately $2,371,951.08. This represents a 2.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

U.S. Physical Therapy Stock Performance

U.S. Physical Therapy stock traded down $1.98 during trading hours on Thursday, reaching $77.86. 385,984 shares of the stock were exchanged, compared to its average volume of 220,158. The stock has a market cap of $1.18 billion, a P/E ratio of 54.83, a P/E/G ratio of 2.02 and a beta of 1.30. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.01. U.S. Physical Therapy, Inc. has a 52-week low of $62.77 and a 52-week high of $93.50. The firm’s 50 day moving average is $83.84 and its 200 day moving average is $82.27.

U.S. Physical Therapy (NYSE:USPH) last issued its earnings results on Thursday, February 26th. The company reported $0.67 earnings per share for the quarter, meeting the consensus estimate of $0.67. U.S. Physical Therapy had a net margin of 5.07% and a return on equity of 8.75%. The business had revenue of $202.73 million for the quarter, compared to the consensus estimate of $200.10 million. During the same quarter in the previous year, the firm earned $0.51 earnings per share. The business’s quarterly revenue was up 12.3% compared to the same quarter last year. Analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 10th. Shareholders of record on Friday, March 13th will be issued a $0.46 dividend. The ex-dividend date of this dividend is Friday, March 13th. This represents a $1.84 dividend on an annualized basis and a yield of 2.4%. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.45. U.S. Physical Therapy’s dividend payout ratio is presently 126.76%.

Institutional Trading of U.S. Physical Therapy

A number of institutional investors have recently bought and sold shares of USPH. Hantz Financial Services Inc. grew its holdings in U.S. Physical Therapy by 56.4% in the fourth quarter. Hantz Financial Services Inc. now owns 366 shares of the company’s stock valued at $29,000 after purchasing an additional 132 shares during the last quarter. Advisory Services Network LLC acquired a new position in shares of U.S. Physical Therapy during the 3rd quarter worth $39,000. EverSource Wealth Advisors LLC boosted its position in shares of U.S. Physical Therapy by 68.8% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 471 shares of the company’s stock worth $40,000 after buying an additional 192 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of U.S. Physical Therapy by 207.1% in the 4th quarter. GAMMA Investing LLC now owns 516 shares of the company’s stock worth $40,000 after buying an additional 348 shares in the last quarter. Finally, Assetmark Inc. grew its stake in U.S. Physical Therapy by 35.7% in the 2nd quarter. Assetmark Inc. now owns 570 shares of the company’s stock valued at $45,000 after acquiring an additional 150 shares during the last quarter.

Analysts Set New Price Targets

Several analysts have recently commented on USPH shares. Barrington Research reissued an “outperform” rating and issued a $103.00 price target on shares of U.S. Physical Therapy in a report on Friday, February 20th. JPMorgan Chase & Co. cut their price objective on U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating for the company in a research report on Monday, November 24th. Weiss Ratings reissued a “hold (c)” rating on shares of U.S. Physical Therapy in a report on Wednesday, January 21st. Jefferies Financial Group started coverage on shares of U.S. Physical Therapy in a research note on Monday. They set a “buy” rating and a $102.00 price target on the stock. Finally, Citigroup reiterated a “market outperform” rating on shares of U.S. Physical Therapy in a report on Monday, December 15th. Five research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $104.50.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.